Aptorum Group Collaborates with Covar Pharmaceuticals To Investigate at Least 3 Repurposed Drug Candidates (SACT-COV19) for Coronavirus Disease 2019 (COVID-19) under Existing Smart-ACT™ Platform and Acticule Infectious Disease Platform

NEW YORK–(BUSINESS WIRE)–Aptorum Group Limited (Nasdaq: APM) („Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics for unmet needs including but not limited to infectious, orphan and metabolic disease areas, today announced that it is initiating an additional research and development project targeting the coronavirus group and has completed initial screening under … Skaityti toliau

FDI World Dental Federation: Global survey shows that less than half (38%) of parents limit their children´s sugary food and drink intake to ensure good oral health

Of the 10 countries surveyed, the United States ranks second last with less than a third of parents limiting sugar levels in their children´s diet.   The UK ranks highest with just over half of parents indicating they restrict sugar levels.   Less than half of parents take their children at least once a year … Skaityti toliau

AOP Orphan, AOP Orphan IP AG and orphanix GmbH join forces to develop RetinolX to prevent bronchopulmonary dysplasia

Vienna (pts036/13.05.2019/13:30) – AOP Orphan IP AG and AOP Orphan Pharmaceuticals AG have entered into a partnership with orphanix GmbH to jointly develop RetinolX, an innovative medicine for the prevention of Bronchopulmonary Dysplasia (BPD). BPD is a life-threatening lung disease affecting very preterm infants. Around 1 % of births are very preterm and potentially affected … Skaityti toliau

AOP Orphan announces three-year results on Ropeginterferon alfa-2b in Polycythemia Vera at ASH

Vienna (pts046/03.12.2018/19:30) – * High rates of durable hematological response and symptom control with good tolerability were reconfirmed with Ropeginterferon alfa-2b after 36 months of treatment. * Disease Modification by Ropeginterferon alfa-2b was illustrated by high molecular response rates, associated with the ability to reduce allelic burden of both mutant JAK2 and importantly also non-JAK2 … Skaityti toliau

FDI white paper and practical guide address the global burden of periodontal disease

Geneva, 16 April 2018 – FDI World Dental Federation published two resources – a white paper and a practical guide – as part of its Global Periodontal Health Project (GPHP), which aims to bring attention to periodontal health as a priority area for policy worldwide. “Periodontal disease – or gum disease as it is often … Skaityti toliau

Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life

Organised by Friends of Cancer Patients More than 2,000 ‘relayers’ take part in inaugural event held in United Arab Emirate SHARJAH, United Arab Emirates–(BUSINESS WIRE)–Sharjah, the third largest of the United Arab Emirate’s seven emirates, was the host for the MENA region’s first ever ‘Global Relay for Life,’ (RFL) a 24-hour walkathon that is the … Skaityti toliau

Don’t underestimate the danger of osteoporosis, warns IOF

Nyon, Switzerland, October-20, 2016 Today, on World Osteoporosis Day, the International Osteoporosis Foundation (IOF) urges all adults to be alert to their risk for osteoporosis, a ‘silent’ disease which causes bones to become fragile and break easily. People with osteoporosis can suffer broken bones as a result of a mere bump or fall from standing … Skaityti toliau